{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:07:17Z","timestamp":1775218037336,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T00:00:00Z","timestamp":1766275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.preghy.2025.101409","type":"journal-article","created":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T04:07:38Z","timestamp":1766808458000},"page":"101409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The sFlt-1\/PlGF ratio test for suspected preeclampsia: an economic assessment in the Netherlands"],"prefix":"10.1016","volume":"43","author":[{"given":"E.J.","family":"Lodewijks","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.E.","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.P.","family":"Bons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Al-Nasiry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.C.J.","family":"Scheepers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.preghy.2025.101409_b0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.preghy.2025.101409_b0010","doi-asserted-by":"crossref","unstructured":"L. Duley, editor The global impact of pre-eclampsia and eclampsia. Seminars in perinatology; 2009: Elsevier.","DOI":"10.1053\/j.semperi.2009.02.010"},{"issue":"9516","key":"10.1016\/j.preghy.2025.101409_b0015","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.preghy.2025.101409_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2013.05.005","article-title":"Global and regional estimates of preeclampsia and eclampsia: a systematic review","volume":"170","author":"Abalos","year":"2013","journal-title":"Eur. J. Obstetr. Gynecol. Reprod. Biol."},{"issue":"1","key":"10.1016\/j.preghy.2025.101409_b0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/HYPERTENSIONAHA.117.10803","article-title":"Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice","volume":"72","author":"Brown","year":"2018","journal-title":"Hypertension"},{"issue":"6","key":"10.1016\/j.preghy.2025.101409_b0030","doi-asserted-by":"crossref","first-page":"E237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational hypertension and preeclampsia","volume":"135","author":"Espinoza","year":"2020","journal-title":"Obstet. Gynecol."},{"issue":"Suppl 1","key":"10.1016\/j.preghy.2025.101409_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The international federation of gynecology and obstetrics (FIGO) initiative on preeclampsia (PE): a pragmatic guide for first trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.preghy.2025.101409_b0040","article-title":"Diagnosis and management of hypertension in pregnancy: summary of updated NICE guidance","volume":"366","author":"Webster","year":"2019","journal-title":"BMJ"},{"issue":"7","key":"10.1016\/j.preghy.2025.101409_b0045","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1373\/clinchem.2016.254920","article-title":"Toward a better diagnosis for preeclampsia","volume":"62","author":"Young","year":"2016","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.preghy.2025.101409_b0050","first-page":"261","article-title":"Prediction of adverse outcomes by common definitions of hypertension in pregnancy","volume":"97","author":"Zhang","year":"2001","journal-title":"Obstet. Gynecol."},{"issue":"12","key":"10.1016\/j.preghy.2025.101409_b0055","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200161","article-title":"Circulating Angiogenic factor levels in hypertensive disorders of pregnancy","volume":"1","author":"Thadhani","year":"2022","journal-title":"NEJM Evidence"},{"issue":"1","key":"10.1016\/j.preghy.2025.101409_b0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1: PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.preghy.2025.101409_b0065","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating antiangiogenic factors in preeclampsia","volume":"355","author":"Levine","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.preghy.2025.101409_b0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/jp.2015.170","article-title":"Analysis of changes in maternal circulating angiogenic factors throughout pregnancy for the prediction of preeclampsia","volume":"36","author":"Honigberg","year":"2016","journal-title":"J. Perinatol."},{"issue":"7","key":"10.1016\/j.preghy.2025.101409_b0075","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1515\/jpm-2022-0127","article-title":"Value of soluble fms-like tyrosine kinase-1\/placental growth factor test in third trimester of pregnancy for predicting preeclampsia in asymptomatic women","volume":"50","author":"Hanson","year":"2022","journal-title":"J. Perinat. Med."},{"issue":"2","key":"10.1016\/j.preghy.2025.101409_b0080","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/HYPERTENSIONAHA.113.01787","article-title":"New gestational phase\u2013specific cutoff values for the use of the soluble fms-like tyrosine kinase-1\/placental growth factor ratio as a diagnostic test for preeclampsia","volume":"63","author":"Verlohren","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.preghy.2025.101409_b0085","article-title":"The race to retain healthcare workers: a systematic review on factors that impact retention of nurses and physicians in hospitals","volume":"60","author":"de Vries","year":"2023","journal-title":"Inquiry"},{"issue":"4","key":"10.1016\/j.preghy.2025.101409_b0090","first-page":"27","article-title":"Health care performance in the Netherlands: easy access, varying quality, rising costs","volume":"16","author":"van den Berg","year":"2011","journal-title":"Eurohealth"},{"key":"10.1016\/j.preghy.2025.101409_b0095","article-title":"Psychosocial stress in high risk pregnancy","volume":"8","author":"Gourounti","year":"2015","journal-title":"Int. Arch. Med."},{"issue":"3","key":"10.1016\/j.preghy.2025.101409_b0100","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/00003081-199809000-00017","article-title":"Psychosocial impact of high-risk pregnancy: hospital and home care","volume":"41","author":"Heaman","year":"1998","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.preghy.2025.101409_b0105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.preghy.2021.08.113","article-title":"Enhancing the value of the sFlt-1\/PlGF ratio for the prediction of preeclampsia: cost analysis from the Belgian healthcare payers\u2019 perspective","volume":"26","author":"Chantraine","year":"2021","journal-title":"Pregnancy Hypertension"},{"issue":"18","key":"10.1016\/j.preghy.2025.101409_b0110","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1080\/14767058.2016.1242122","article-title":"Budget impact analysis of sFlt-1\/PlGF ratio as prediction test in Italian women with suspected preeclampsia","volume":"30","author":"Frusca","year":"2017","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"10.1016\/j.preghy.2025.101409_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vhri.2022.09.003","article-title":"Economic impact analysis of incorporation of elecsys sFlt-1\/PlGF ratio into routine practice for the diagnosis and follow-up of pregnant women with suspected preeclampsia in Argentina","volume":"34","author":"Garay","year":"2023","journal-title":"Value Health Regional Issues"},{"key":"10.1016\/j.preghy.2025.101409_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12913-018-3406-1","article-title":"Economic assessment of the use of the sFlt-1\/PlGF ratio test to predict preeclampsia in Germany","volume":"18","author":"Schlembach","year":"2018","journal-title":"BMC Health Serv. Res."},{"issue":"6","key":"10.1016\/j.preghy.2025.101409_b0125","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/uog.15997","article-title":"sFlt\u20101\/PlGF ratio test for pre\u2010eclampsia: an economic assessment for the UK","volume":"48","author":"Vatish","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"7","key":"10.1016\/j.preghy.2025.101409_b0130","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41440-021-00624-2","article-title":"Economic evaluation of the sFlt-1\/PlGF ratio for the short-term prediction of preeclampsia in a Japanese cohort of the PROGNOSIS Asia study","volume":"44","author":"Ohkuchi","year":"2021","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.preghy.2025.101409_b0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.preghy.2018.04.014","article-title":"Economic evaluation of sFlt-1\/PlGF ratio test in pre-eclampsia prediction and diagnosis in two Brazilian hospitals","volume":"13","author":"Figueira","year":"2018","journal-title":"Pregnancy Hypertension"},{"issue":"3","key":"10.1016\/j.preghy.2025.101409_b0140","article-title":"Economic analysis of the use of the Flt-1\/PlGF preeclampsia ratio compared to the standard of care in Uruguay","volume":"75","author":"Gui\u00f1az\u00fa","year":"2024","journal-title":"Revista Colombiana De Obstetricia y Ginecolog\u00eda"},{"issue":"1","key":"10.1016\/j.preghy.2025.101409_b0145","article-title":"sFlt\u20101\/PlGF ratio as a predictive marker in women with suspected preeclampsia: an economic evaluation from a swiss perspective","volume":"2019","author":"Hodel","year":"2019","journal-title":"Dis. Markers"},{"key":"10.1016\/j.preghy.2025.101409_b0150","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.preghy.2021.10.009","article-title":"Cost effectiveness of the sFlt1\/PlGF ratio test as an adjunct to the current practice of evaluating suspected preeclampsia in the United States","volume":"26","author":"Khosla","year":"2021","journal-title":"Pregnancy Hypertension"},{"issue":"12","key":"10.1016\/j.preghy.2025.101409_b0155","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s40273-021-01104-8","article-title":"Health-economic analyses of diagnostics: guidance on design and reporting","volume":"39","author":"van der Pol","year":"2021","journal-title":"Pharmacoeconomics"},{"issue":"1","key":"10.1016\/j.preghy.2025.101409_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2393-14-324","article-title":"Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol","volume":"14","author":"Hund","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.preghy.2025.101409_b0165","unstructured":"V. der Heijden. Hypertensieve aandoeningen in de zwangerschap."},{"issue":"3","key":"10.1016\/j.preghy.2025.101409_b0170","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/uog.19178","article-title":"Soluble fms\u2010like tyrosine kinase\u20101 to placental growth factor ratio: ruling out pre\u2010eclampsia for up to 4 weeks and value of retesting","volume":"53","author":"Zeisler","year":"2019","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"1","key":"10.1016\/j.preghy.2025.101409_b0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12884-022-05254-1","article-title":"Clinical value and cost analysis of the sFlt-1\/PlGF ratio in addition to the spot urine protein\/creatinine ratio in women with suspected pre-eclampsia: PREPARE cohort study","volume":"22","author":"Wind","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"issue":"11","key":"10.1016\/j.preghy.2025.101409_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187477","article-title":"Update of the dutch manual for costing studies in health care","volume":"12","author":"Kanters","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.preghy.2025.101409_b0185","unstructured":"ZorginstituutNederland. Betamethason [Available from: https:\/\/www.farmacotherapeutischkompas.nl\/bladeren\/preparaatteksten\/b\/betamethason__systemisch_#kosten."},{"key":"10.1016\/j.preghy.2025.101409_b0190","unstructured":"ZorginstituutNederland. Labetalol [Available from: https:\/\/www.farmacotherapeutischkompas.nl\/bladeren\/preparaatteksten\/l\/labetalol."},{"key":"10.1016\/j.preghy.2025.101409_b0195","unstructured":"ZorginstituutNederland. Nefidipine [Available from: https:\/\/www.farmacotherapeutischkompas.nl\/bladeren\/preparaatteksten\/n\/nifedipine."},{"key":"10.1016\/j.preghy.2025.101409_b0200","unstructured":"ZorginstituutNederland. Methyldopa [Available from: https:\/\/www.farmacotherapeutischkompas.nl\/bladeren\/preparaatteksten\/m\/methyldopa."},{"issue":"6","key":"10.1016\/j.preghy.2025.101409_b0205","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/0962280211419832","article-title":"Probabilistic sensitivity analysis in health economics","volume":"24","author":"Baio","year":"2015","journal-title":"Stat. Methods Med. Res."},{"issue":"2","key":"10.1016\/j.preghy.2025.101409_b0210","article-title":"Cost-effectiveness of the sFlt-1\/PlGF ratio test in pregnant patients with suspected pre-eclampsia: a systematic review","volume":"5","author":"Goutallier","year":"2025","journal-title":"AJOG Glob. Rep."},{"issue":"12","key":"10.1016\/j.preghy.2025.101409_b0215","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1111\/jan.15052","article-title":"The implementation of a professional practice model to improve the nurse work environment in a Dutch hospital: a quasi\u2010experimental study","volume":"77","author":"Bloemhof","year":"2021","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.preghy.2025.101409_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.preghy.2025.101190","article-title":"Neonatal cost savings in hypertensive disorders of pregnancy: economic evaluation of the sFlt-1\/PlGF test with real world implementation of biomarkers","volume":"39","author":"Azzi","year":"2025","journal-title":"Pregnancy Hypertens."},{"issue":"1","key":"10.1016\/j.preghy.2025.101409_b0225","doi-asserted-by":"crossref","first-page":"ix","DOI":"10.3109\/10641950109152635","article-title":"The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the international society for the study of hypertension in pregnancy (ISSHP)","volume":"20","author":"Brown","year":"2001","journal-title":"Hypertens. Pregnancy"},{"key":"10.1016\/j.preghy.2025.101409_b0230","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.preghy.2021.09.008","article-title":"The 2021 international society for the study of hypertension in pregnancy classification, diagnosis & management recommendations for international practice","volume":"27","author":"Magee","year":"2022","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.preghy.2025.101409_b0235","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.preghy.2019.11.011","article-title":"Evaluation of the clinical impact of the revised ISSHP and ACOG definitions on preeclampsia","volume":"19","author":"Bouter","year":"2020","journal-title":"Pregnancy Hypertens."}],"container-title":["Pregnancy Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778925002259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778925002259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T11:30:58Z","timestamp":1775215858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778925002259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":47,"alternative-id":["S2210778925002259"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2025.101409","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The sFlt-1\/PlGF ratio test for suspected preeclampsia: an economic assessment in the Netherlands","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2025.101409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of International Society for the Study of Hypertension in Pregnancy.","name":"copyright","label":"Copyright"}],"article-number":"101409"}}